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On page 393, Figure 1, "Maintenance period (month 6 to 24)" should be "Maintenance period (month 4 to 24)"; "-- Gal at stable dose (at least 18 mg/day) as achieved on day 84^c^" should be "-- Gal at stable dose (at least 16 mg/day) as achieved on day 84^c^". The correct figure is shown below.

![**Notes:** ^a^Uptitration (from 16 mg/day to 24 mg/day) or downtitration (from 24 mg/day to 16 mg/day) of dose was allowed, based on tolerability and the investigator's judgment. Patients unable to tolerate a minimum of 16 mg/day dose were to discontinue treatment and were followed until the end of the maintenance and posttreatment period. The total number of patients included in the safety analysis set was n=2,045; ^b^early study termination, per Data Safety Monitoring Board recommendation, when the prespecified number of deaths was ascertained and a significant imbalance favoring galantamine was observed; ^c^a one-time dose titration to 16 or 24 mg/day was allowed, based on the investigator's judgment and patient tolerability.\
**Abbreviation:** Gal, galantamine.](ndt-10-1997Fig1){#f1-ndt-10-1997}
